This page lists 12 hormone therapy doctors in Hyderabad, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Hormone Therapy doctors in Hyderabad, India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Hormone Therapy doctors
FeaturedDr. Bharat Vaswani
- 26+ years of experience in Medical Oncologist & Hematologist
- Clinical Director — Medical Oncology & Hematology, Yashoda Hospitals, Secunderabad, Present
- Senior Consultant Medical Oncologist, SevenStar Hospital, Nagpur
- Chemotherapy Administration and Management
- Cancer Immunotherapy
- Targeted Molecular Therapy
- Hormone Therapy for Breast Cancer
- Hematological Malignancy Treatment

Dr. Harish Kancharla
- 14+ years of experience in Medical Oncologist and Hemato-Oncologist
- Consultant, Medical Oncology and Hemato-Oncology, Yashoda Hospitals, Hyderabad — Present
- Senior Resident/Fellow, Medical Oncology, AIIMS Delhi — 2017–2020
- Chemotherapy (conventional cytotoxic and targeted agents)
- Cancer immunotherapy and immune checkpoint inhibitor therapy
- Hormone therapy for breast and urogenital cancers
- Bone marrow transplantation and stem cell therapy
- Palliative care and symptom management

Dr. Macha Kiran Kumar
- 13+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology — Yashoda Hospitals, Secunderabad (Present)
- Consultant, Medical Oncology — Medicover Cancer Institute, Hitec City, Hyderabad
- Chemotherapy Administration and Management
- Cancer Immunotherapy and Checkpoint Inhibitors
- Targeted Molecular Therapy
- Hormone Therapy for Breast Cancer
- Autologous Stem Cell Transplantation

Dr. Naidu N. Bethune
- 21+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Yashoda Hospitals, Hi-Tech City, Hyderabad (Present)
- Consultant — Medical Oncology, American Oncology Institute, Hyderabad
- Chemotherapy Administration for Solid and Hematological Cancers
- Targeted Therapy and Molecular Cancer Treatment
- Cancer Immunotherapy and Checkpoint Inhibitors
- Stem Cell Transplantation
- Bone Marrow Transplantation

Dr. Nikhil Suresh Ghadyalpatil
- 18+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology, Apollo Hospital, Jubilee Hills, Hyderabad — Present
- Specialist in hemato-oncology and translational cancer research across leading Indian oncology centres
- Chemotherapy Administration for Solid Tumours
- Immunotherapy and Immune Checkpoint Inhibitor Therapy
- Molecular Targeted Therapy Planning
- Hormone Therapy for Breast and Prostate Cancer
- Adjuvant Chemotherapy Management

Dr. Rekha Bansal
- 8+ years of experience in Medical Oncologist
- Consultant, Medical Oncology — Apollo Hospital, Jubilee Hills, Hyderabad (Present)
- Over 8 years of clinical experience in oncology and cancer management across tertiary care settings
- Adjuvant Chemotherapy for Solid Tumors
- Neoadjuvant Chemotherapy Planning
- Palliative Chemotherapy Management
- Immunotherapy with Checkpoint Inhibitors
- Molecular Targeted Therapy

Dr. S V S S Prasad
- 26+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology, Apollo Hospital Jubilee Hills, Hyderabad — Present
- 26+ years of clinical experience in medical oncology across government and private institutions
- Systemic chemotherapy planning and administration
- Immune checkpoint inhibitor therapy
- Targeted molecular therapy
- Hormone therapy for breast and gynecologic cancers
- Adjuvant and neoadjuvant chemotherapy

Dr. Shikhar Kumar
- 13+ years of experience in Medical Oncologist
- Consultant Medical Oncologist, Yashoda Hospitals, Hyderabad — Present
- Assistant Professor (Ad-Hoc), Tata Memorial Hospital, Mumbai — 2020–2021
- Chemotherapy administration and management
- Cancer immunotherapy and checkpoint inhibitor therapy
- Targeted cancer therapy
- Hormone therapy for breast and prostate cancer
- Hematologic malignancy treatment

Dr. Srinivas Chakravarthy G
- 26+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology, Yashoda Hospitals, Secunderabad, Hyderabad, India — Present
- Consultant Hematologist and Medical Oncologist, various leading hospitals in Hyderabad and USA — 26+ years
- Systemic Chemotherapy Administration
- Targeted Molecular Therapy
- Cancer Immunotherapy (CAR-T, Checkpoint Inhibitors)
- Hormone Therapy for Breast and Prostate Cancer
- Hematopoietic Stem Cell Transplantation

Dr. Sudha Sinha
- 23+ years of experience in Medical Oncologist
- Clinical Director, HOD, and Senior Consultant in Medical Oncology — Yashoda Hospital, Hyderabad, India (Present)
- Consultant Medical Oncologist — Care Hospitals, Hyderabad, India
- Chemotherapy Administration and Management
- CAR-T Cell Therapy
- Cancer Immunotherapy
- Targeted Therapy for Solid Tumors
- Hormone Therapy for Breast Cancer
Hospitals where these doctors practise
Medicover Hospital Hitec City
Apollo Hospitals, Jubilee Hills
Why consider treatment in India?
Many international patients consider India for breast cancer treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
What is Hormone Therapy?
Hormone therapy uses medications or surgery to block or lower the effect of hormones that fuel certain cancers, most commonly hormone receptor-positive breast cancer and prostate cancer. It is used as a primary treatment, alongside surgery/radiation, or to reduce recurrence risk, and can be delivered as daily oral tablets, periodic injections, or surgical hormone ablation. GAF Healthcare connects patients with leading Indian oncologists offering evidence-based hormone therapy protocols with close monitoring and significant cost savings compared to Western countries.
Who may be considered?
Hormone Therapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Daily oral medication that blocks estrogen receptors or lowers estrogen production, used for hormone receptor-positive breast cancer, typically for 5-10 years with periodic monitoring.
Oral Hormone Therapy (Tamoxifen / Aromatase Inhibitors) – Breast Cancer
Most CommonDaily oral medication that blocks estrogen receptors or lowers estrogen production, used for hormone receptor-positive breast cancer, typically for 5-10 years with periodic monitoring.
Comprehensive Investigations
Hormone receptor (ER/PR/HER2) testing, CBC, liver function tests (LFT), bone density scan (DEXA), pelvic ultrasound, mammogram
Treatment / Procedure Estimate
Stay in India
Usually Included in Hospital Package
- Oncologist consultation
- Baseline lab and imaging review
- Medication prescription and initiation
- Treatment plan documentation
- Care coordinator support
Usually Not Included
- Ongoing medication supply after leaving India
- Long-term DEXA/imaging follow-up abroad
- Airfare and accommodation
- Management of unrelated pre-existing conditions
Recovery and follow-up
Oral and injectable hormone therapies are typically continued for months to years with follow-up every 3-6 months to monitor hormone levels, bone density, and side effects, while surgical hormone ablation requires about 1-2 weeks of physical recovery before resuming normal activities.
Risks
Common risks include hot flashes, fatigue, mood changes, reduced bone density, and increased cardiovascular or blood clot risk with long-term hormone therapy; surgical ablation carries standard surgical risks such as bleeding or infection and is irreversible.
Alternatives
Alternatives include chemotherapy, targeted therapy (e.g., HER2-directed agents), radiation therapy, definitive surgery (mastectomy or radical prostatectomy), or active surveillance for select low-risk cases.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Pathology/biopsy report confirming cancer type and hormone receptor status
- PSA levels and trend (for prostate cancer)
- Mammogram/breast imaging or CT/bone scan (as applicable)
- Recent CBC and liver function tests (LFT)
- Bone density (DEXA) scan report, if available
- Details of prior treatments (surgery, chemotherapy, radiation)
- Latest oncologist consultation notes and treatment plan
- List of current medications and allergies
Patient information needed
- Patient age, gender, and menopausal status (for breast cancer)
- Type and stage of cancer
- Current and past hormone-related or cancer medications
- Comorbidities such as diabetes, heart disease, or osteoporosis
- History of blood clots or cardiovascular disease
- Family history of hormone-sensitive cancers
- Availability of a travel companion/caregiver
- Preferred treatment start date and duration of stay in India
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Hormone Therapy) and procedure (Hormone Therapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
